Managing patients with amyotrophic lateral sclerosis

European Journal of Internal Medicine

Volumn 20, Issue 4, 2009, Pages 355-358

  Sathasivam, Sivakumar ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Management; Quality of life; Survival

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; RILUZOLE; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; DEPRESSION; EUTHANASIA; FATIGUE; HUMAN; HYPERSALIVATION; NUTRITION; PAIN; PSEUDOBULBAR PALSY; QUALITY OF LIFE; RESPIRATORY CARE; REVIEW; SPASTICITY; SURVIVAL;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; PATIENT CARE TEAM; QUALITY OF LIFE;

EID: 67349171500     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.09.002     Document Type: Review

References (56)

1. Charcot J.M. Sclérose des cordons latéraux de la moelle epinierè chez une femme hysterique, atteinte de contracture permanente des quatre membres. Bull Soc Med Hopit Paris (1865) 24-35
2. Mitchell J.D., and Borasio G.D. Amyotrophic lateral sclerosis. Lancet 369 (2007) 2031-2041
3. Borasio G.D., Sloan R., and Pongratz D.E. Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci 160 Suppl 1 (1998) S127-133
4. Miller R.G., Mitchell J.D., Lyon M., and Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 1 (2007) CD001447
5. Bensimon G., Lacomblez L., Delumeau J.C., et al. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol 249 (2002) 609-615
6. Bourke S.C., Tomlinson M., Williams T.L., Bullock R.E., Shaw P.J., and Gibson G.J. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5 (2006) 140-147
7. Miller R.G., Rosenberg J.A., Gelinas D.F., et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52 (1999) 1311-1323
8. Fitting J.W., Paillex R., Hirt L., et al. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 46 (1999) 887-893
9. Lyall R.A., Donaldson N., Polkey M.I., Aebischer P., and Schluep M. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 124 (2001) 2000-2013
10. Hayashi H., and Oppenheimer E.A. ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications. Neurology 61 (2003) 135-137
11. Moss A.H., Casey P., Stocking C.B., Roos R.P., Brooks B.R., and Siegler M. Home ventilation for amyotrophic lateral sclerosis: outcomes, costs, and patient, family, and physician attitudes. Neurology 43 (1993) 438-443
12. Cazzolli P.A., and Oppenheimer E.A. Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation. J Neurol Sci 139 (1996) 123-128
13. Vaszar L.T., Weinacker A.B., Henig N.R., and Raffin T.A. Ethical issues in the long-term management of progressive degenerative neuromuscular diseases. Semin Respir Crit Care Med 23 (2002) 307-314
14. Desport J.C., Preux P.M., Truong T.C., Vallat J.M., Sautereau D., and Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53 (1999) 1059-1063
15. Mazzini L., Corra T., Zaccala M., Mora G., Del Piano M., and Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 242 (1995) 695-698
16. Desport J.C., Preux P.M., Truong C.T., Courat L., Vallat J.M., and Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 91-96
17. Mathus-Vliegen L.M., Louwerse L.S., Merkus M.P., Tytgat G.N., and Vianney de Jong J.M. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 40 (1994) 463-469
18. Kasarskis E.J., Scarlata D., Hill R., Fuller C., Stambler N., and Cedarbaum J.M. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169 (2002) 118-125
19. Thornton F.J., Fotheringham T., Alexander M., Hardiman O., McGrath F.P., and Lee M.J. Amyotrophic lateral sclerosis - enteral nutrition provision: endoscopic or radiologic gastrostomy?. Radiology 224 (2002) 713-717
20. Chio A., Galletti R., Finocchiaro C., et al. Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry 75 (2004) 645-647
21. Andersen P.M., Borasio G.D., Dengler R., et al. EFNS Task Force on management of Amyotrophic Lateral Sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 12 (2005) 921-938
22. Leigh P.N., Abrahams S., Al-Chalabi A., et al. The management of motor neurone disease. J Neurol Neurosurg Psychiatry 74 Suppl 4 (2003) iv32-47
23. Newall A.R., Orser R., and Hunt M. The control of oral secretions in bulbar ALS/MND. J Neurol Sci 139 Suppl (1996) 43-44
24. Verma A., and Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 34 (2006) 235-237
25. Borasio G., and Voltz R. Palliative care in amyotrophic lateral sclerosis. J Neurol 244 (1997) S11-17
26. Kurland L.T., and Mulder D.W. Epidemiologic investigations of amyotrophic lateral sclerosis: 2. Familial aggregations indicative of dominant inheritance part II. Neurology 5 (1955) 249-268
27. Schiffer R.B., Cash J., and Herndon R.M. Treatment of emotional lability with low-dosage tricyclic antidepressants. Psychosomatics 24 (1983) 1094-1096
28. Iannaccone S., and Ferini-Strambi L. Pharmacologic treatment of emotional lability. Clin Neuropharmacol 19 (1996) 532-535
29. O'Brien T., Kelly M., and Saunders C. Motor neuron disease: a hospice perspective. BMJ 304 (1992) 471-473
30. Kanaan N., and Sawaya R. Nocturnal leg cramps. Clinically mysterious and painful - but manageable. Geriatrics 56 34 (2001) 39-42
31. Carter G.T., and Miller R.G. Comprehensive management of amyotrophic lateral sclerosis. Phys Med Rehab Clin 9 (1998) 271-284
32. Marquardt G., and Lorenz R. Intrathecal baclofen for intractable spasticity in amyotrophic lateral sclerosis. J Neurol 246 (1999) 619-620
33. Restivo D.A., Lanza S., Marchese-Ragona E., and Palmeri A. Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis. Gastroenterology 123 (2002) 1749-1750
34. Krivickas L.S. Exercise in neuromuscular disease. J Clin Neoromusc Dis 5 (2003) 29-39
35. Kilmer D.D., McCrory M.A., Wright N.C., et al. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 75 (1994) 560-563
36. Carter G.T., Weiss M.D., Lou J.S., et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care 22 (2005) 55-59
37. Francis K., Bach J.R., and DeLisa J.A. Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 80 (1999) 951-963
38. Brownlee A., and Palovcak M. The role of augmentative communication devices in the medical management of ALS. Neurorehabilitation 22 (2007) 445-450
39. Kurt A., Nijboer F., Matuz T., and Kubler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 21 (2007) 279-291
40. Veldink J.H., Wokke J.H.J., van der Wal G., Vianney de Jong J.M., and van den Berg L.H. Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in The Netherlands. N Engl J Med 346 (2002) 1638-1644
41. Ganzini L., Johnston W.S., McFarland B.H., Tolle S.W., and Lee M.A. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide. N Engl J Med 339 (1998) 967-973
42. Minkoff K., Bergman E., Beck A.T., and Beck R. Hopelessness, depression, and attempted suicide. Am J Psychiatry 130 (1973) 455-459
43. Beck A.T., Brown G., Berchick R.J., Stewart B.L., and Steer R.A. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry 147 (1990) 190-195
44. Appel S.H. Euthanasia and physician-assisted suicide in ALS: a commentary. Am J Hosp Palliat Care 21 (2004) 405-406
45. Johnston M., Earll L., Mitchell E., Morrison V., and Wright S. Communicating the diagnosis of motor neurone disease. Palliat Med 10 (1996) 23-34
46. Neudert C., Oliver D., Wasner M., and Borasio G.D. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 248 (2001) 612-616
47. WHOQOL: Measuring quality of life. Geneva: World Health Organization. 1997. www.who.int/mental_health/media/68.pdf.
48. Simmons Z., Bremer B.A., Robbins R.A., Walsh S.M., and Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology 55 (2000) 388-392
49. Robbins R.A., Simmons Z., Bremer B.A., Walsh S.M., and Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology 56 (2001) 442-444
50. Murphy P.L., Albert S.M., Weber C., Del Bene M.L., and Rowland L.P. Impact of spirituality and religiousness on outcomes in patients with ALS. Neurology 55 (2000) 1581-1584
51. Goldstein L.H., Atkins L., and Leigh P.N. Correlates of quality of life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 3 (2002) 123-129
52. Krivickas L.S., Shockley L., and Mitsumoto H. Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci 152 Suppl 1 (1997) S82-89
53. Mitsumoto H. Caregiver assessment: summary. Amyotroph Lateral Scler Other Motor Neuron Disord 3 Suppl 1 (2002) S31-34
54. Traynor B.J., Alexander M., Corr B., Frost E., and Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 74 (2003) 1258-1261
55. Chio A., Bottacchi E., Buffa C., Mutani R., Mora G., and PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry 77 (2006) 948-950
56. Van den Berg J.P., Kalmijn S., Lindeman E., et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 65 (2005) 1264-1267